What is it about?
Citicoline is hypothesized to improve the cholinergic system of the brain. Two retrospective cohorts involving 563 patients were analyzed in this review. Limited evidence suggests that citicoline as adjunct may improve cognitive function.
Featured Image
Photo by Steven HWG on Unsplash
Why is it important?
We believe this publication will be of great importance to the scientific community as this study determined the effects of citicoline as an adjunct treatment to acetylcholinesterase inhibitors for patients with Alzheimer disease through systematic review of relevant studies.
Perspectives
Writing this review was enlightening and insightful. It was also a great opportunity to work with co-authors whom I have had a great long standing collaborations.
Bernadeth Lyn Piamonte
University of the Philippines System
Read the Original
This page is a summary of: Effects of Citicoline as an Adjunct Treatment for Alzheimer’s Disease: A Systematic Review, Journal of Alzheimer s Disease, June 2020, IOS Press,
DOI: 10.3233/jad-200378.
You can read the full text:
Resources
Contributors
The following have contributed to this page
